June 2018

FDA action; gene discover in ALL

Coverage of the latest clinical updates in cancer research.

Lessons from the first meeting of The American Journal of Managed Care® Population Health Council.

AJMC® Convenes First Gathering of Institute for Value-Based Medicine to Share Best Practices in New Payment Models in Cancer Care

Authors from Foundation Medicine explain the regulatory path that led to approval of FoundationOne CDx.

Film is truth 24 times a second, and every cut is a lie – Jean-Luc Godard

Flatiron Health recently conducted a retrospective review of the Oncology Care Model, discovering what's working, what isn't, and what this could mean for the future.

"It is time for patients to have more control over what is prescribed to them and technologies like chemoWave are giving them that power." A cancer diagnosis leads to chemoWave, an app for recording patient-reported outcomes.

Accurate prediction of the natural history of prostate cancer is necessary to avoid overtreatment, which increases the morbidity rate in men and is costly to the healthcare system. Biomarkers, or molecular testing of the prostate cancer tumor tissue, can more accurately predict the aggressiveness of prostate cancer and help physicians determine who needs definitive treatment and who can safely pursue active surveillance.

Telehealth, a universal term for the use of digital information and communication technologies to remotely access healthcare services, is improving availability of healthcare services, particularly for patients in rural areas.